Biomarkers投稿须知

期刊简介

《Biomarkers》是由Informa Healthcare出版社于1996年创办的英文国际期刊（ISSN: 1354-750X，E-ISSN: 1366-5804），该期刊长期致力于生物工程与应用微生物领域的创新研究，主要研究方向为医学-毒理学。作为SCIE收录期刊（JCR分区 Q3，中科院 4区），本刊采用OA未开放获取模式（OA占比0.0321...%），以发表生物工程与应用微生物领域等方向的原创性研究为核心（研究类文章占比76.19%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在42篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Biomarkers审稿周期约为约3.0个月。该刊近年未被列入国际预警名单，年发文量约42篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
42 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 TOXICOLOGY 毒理学 4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 TOXICOLOGY 毒理学 4区 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q3	128 / 174	26.7%
学科：TOXICOLOGY	SCIE	Q4	80 / 106	25%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q3	116 / 174	33.62%
学科：TOXICOLOGY	SCIE	Q3	78 / 106	26.89%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：5

SJR：0.534

SNIP：0.573

学科类别	分区	排名	百分位
大类：Environmental Science 小类：Health, Toxicology and Mutagenesis	Q2	68 / 148	54%
大类：Environmental Science 小类：Clinical Biochemistry	Q2	58 / 117	50%
大类：Environmental Science 小类：Biochemistry	Q3	245 / 438	44%

期刊发文

Long noncoding RNA as a potential diagnostic tool for prostate cancer: a systematic review and meta-analysis
Author: Li, Yexin; Wei, Chunmeng; Huang, Caihong; Ling, Qiang; Zhang, Lulu; Huang, Shengzhu; Liao, Naikai; Liang, Weixia; Cheng, Jiwen; Wang, Fubo; Mo, Linjian; Mo, Zengnan; Li, Longman

Journal: BIOMARKERS. 2023; Vol. 28, Issue 1, pp. 1-10. DOI: 10.1080/1354750X.2022.2142293
Diagnostic and prognostic value of secreted phosphoprotein 1 for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Author: Liao, Yi; Wang, Ran; Wen, Fuqiang

Journal: BIOMARKERS. 2023; Vol. 28, Issue 1, pp. 87-96. DOI: 10.1080/1354750X.2022.2148744
LCK, FOXC1 and hsa-miR-146a-5p as potential immune effector molecules associated with rheumatoid arthritis
Author: Chen, Xuemeng; Xie, Li; Jiang, Yi; Zhang, Ronghua; Wu, Wei

Journal: BIOMARKERS. 2023; Vol. 28, Issue 1, pp. 130-138. DOI: 10.1080/1354750X.2022.2150315
Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance
Author: Hoque, Saminur; Dhar, Rajib; Kar, Rishav; Mukherjee, Sayantanee; Mukherjee, Dattatreya; Mukerjee, Nobendu; Nag, Sagnik; Tomar, Namrata; Mallik, Saurav

Journal: BIOMARKERS. 2023; Vol. 28, Issue 2, pp. 139-151. DOI: 10.1080/1354750X.2022.2157875
Pre-treatment systemic immune-inflammation index as a non-invasive biomarker for predicting clinical outcomes in patients with renal cell carcinoma: a meta-analysis of 20 studies
Author: Xu, Jun; Song, Junying; Yang, Zhenhua; Zhao, Jianguo; Wang, Jianfang; Sun, Caiping; Zhu, Xiaoling

Journal: BIOMARKERS. 2023; Vol. 28, Issue 3, pp. 249-262. DOI: 10.1080/1354750X.2023.2164906
Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population
Author: Zhang, Nan; Wang, Jianfeng; Zhang, Shigeng; Wu, Huifeng; Li, Zhongyi; Hu, Maolin

Journal: BIOMARKERS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/1354750X.2023.2166587
The role of differentially expressed miR-660 in peripheral blood lymphocytes of patients with pulmonary tuberculosis
Author: Lin, Mu; Liu, Mubo; Han, Xiaojing; Tao, Xue; Tang, Zhu; Ma, Qingqing

Journal: BIOMARKERS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/1354750X.2023.2198166
ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer
Author: Liu, Siyu; Cao, Xiaobin; Li, Jing; Liu, Jingjing

Journal: BIOMARKERS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/1354750X.2023.2201665

Biomarkers

生物标志物

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询